Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Leukemia Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00349596
What this trial is testing

Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)

Who this might be right for
Acute Lymphocytic Leukemia
M.D. Anderson Cancer Center 40
Early research (Phase 1)Looking for participantsNCT06208735
What this trial is testing

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Who this might be right for
B-Cell LeukemiaNon-Hodgkin's LymphomaB-cell Acute Lymphoblastic Leukemia+5 more
British Columbia Cancer Agency 24
Testing effectiveness (Phase 2)Study completedNCT01363297
What this trial is testing

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Pfizer 72
Early research (Phase 1)Study completedNCT01321346
What this trial is testing

Panobinostat In Children With Refractory Hematologic Malignancies

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more
Therapeutic Advances in Childhood Leukemia Consortium 30
Early research (Phase 1)Looking for participantsNCT05735184
What this trial is testing

Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaMixed Lineage Leukemia Gene MutationRefractory AML+7 more
Kura Oncology, Inc. 420
Early research (Phase 1)Active Not RecruitingNCT04606433
What this trial is testing

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd. 47
Very early researchLooking for participantsNCT06696833
What this trial is testing

Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Soochow University 18
Early research (Phase 1)Study completedNCT02096289
What this trial is testing

Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Ontario Clinical Oncology Group (OCOG) 13
Early research (Phase 1)Active Not RecruitingNCT03190278
What this trial is testing

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
Cellectis S.A. 29
Not applicableStudy completedNCT00919425
What this trial is testing

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 1,294
Testing effectiveness (Phase 2)Ended earlyNCT05886491
What this trial is testing

GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia
Takeda 16
Testing effectiveness (Phase 2)Study completedNCT01702155
What this trial is testing

Phase I/II Study of DFP-10917 in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic Leukemia
Delta-Fly Pharma, Inc. 69
Early research (Phase 1)Study completedNCT03181126
What this trial is testing

Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Lymphoblastic Lymphoma
AbbVie 69
Very early researchUnknownNCT05574608
What this trial is testing

Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia Recurrent
Affiliated Hospital to Academy of Military Medical Sciences 12
Testing effectiveness (Phase 2)WithdrawnNCT04354025
What this trial is testing

Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML

Who this might be right for
Refractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia
Washington University School of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT03071276
What this trial is testing

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
St. Jude Children's Research Hospital 37
Very early researchWithdrawnNCT07196111
What this trial is testing

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Who this might be right for
B Acute Lymphoblastic Leukemia/Lymphoma
Guangzhou Bio-gene Technology Co., Ltd
Early research (Phase 1)Study completedNCT00077467
What this trial is testing

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00004009
What this trial is testing

R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Maryland, Baltimore
Early research (Phase 1)WithdrawnNCT05521087
What this trial is testing

JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias

Who this might be right for
Acute LeukemiasAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more
Janssen Research & Development, LLC
Next Page